HEMOGLOBIN CONTRAST IN ULTRASOUND AND OPTICAL COHERENCE TOMOGRAPHY FOR DIAGNOSING DISEASED TISSUE, CANCERS, AND THE LIKE
Patent №
US 9,204,802
Granted
2015-12-08
Filed 2011
Owner
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Lab
—
AI components
1
vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13330258
A novel contrast mechanism for diagnosing diseased tissue using Ultrasound, Doppler Ultrasonography, Optical Coherence Tomography, or optical Doppler tomography coupled with an externally applied temporally oscillating high-strength magnetic field.
AI classification
Ownership
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
assignment · 277190944
Assignors
FELDMAN, MARC D., MILNER, THOMAS E., OH, JUNG-HWAN, FELDMAN, MARC D., OH, JUNG-HWAN, MILNER, THOMAS E.
On an employer assignment, the assignors are typically the inventors.